Early modulation of the gut microbiome by female sex hormones alters amyloid pathology and microglial function
Piyali Saha,Ian Q. Weigle,Nicholas Slimmon,Pedro Blauth Poli,Priyam Patel,Xiaoqiong Zhang,Yajun Cao,Julia Michalkiewicz,Ashley Gomm,Can Zhang,Rudolph E. Tanzi,Nicholas Dylla,Ayman Al-Hendy,Sangram S. Sisodia
DOI: https://doi.org/10.1038/s41598-024-52246-6
IF: 4.6
2024-01-23
Scientific Reports
Abstract:It is well-established that women are disproportionately affected by Alzheimer's disease. The mechanisms underlying this sex-specific disparity are not fully understood, but several factors that are often associated-including interactions of sex hormones, genetic factors, and the gut microbiome-likely contribute to the disease's etiology. Here, we have examined the role of sex hormones and the gut microbiome in mediating Aβ amyloidosis and neuroinflammation in APPPS1-21 mice. We report that postnatal gut microbiome perturbation in female APPPS1-21 mice leads to an elevation in levels of circulating estradiol. Early stage ovariectomy (OVX) leads to a reduction of plasma estradiol that is correlated with a significant alteration of gut microbiome composition and reduction in Aβ pathology. On the other hand, supplementation of OVX-treated animals with estradiol restores Aβ burden and influences gut microbiome composition. The reduction of Aβ pathology with OVX is paralleled by diminished levels of plaque-associated microglia that acquire a neurodegenerative phenotype (MGnD-type) while estradiol supplementation of OVX-treated animals leads to a restoration of activated microglia around plaques. In summary, our investigation elucidates the complex interplay between sex-specific hormonal modulations, gut microbiome dynamics, metabolic perturbations, and microglial functionality in the pathogenesis of Alzheimer's disease.
multidisciplinary sciences